Gyre Therapeutics Third Quarter 2024 Earnings EPS US0.013
GYRE Stock | 11.50 0.67 6.19% |
About 62% of all Gyre Therapeutics' shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding Gyre Therapeutics suggests that some traders are interested. The current market sentiment, together with Gyre Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Gyre Therapeutics stock news signals to limit their universe of possible portfolio assets.
Gyre Therapeutics Third Quarter 2024 Results Key Financial Results Revenue US25.5m down 17 percent from 3Q...
Read at simplywall.st
![]() |
Gyre Therapeutics Current Investor Sentiment
Comfort Level 62
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Gyre Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Gyre Therapeutics.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
Gyre Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Gyre Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Gyre Therapeutics Historical Investor Sentiment
Investor biases related to Gyre Therapeutics' public news can be used to forecast risks associated with an investment in Gyre. The trend in average sentiment can be used to explain how an investor holding Gyre can time the market purely based on public headlines and social activities around Gyre Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Gyre Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Gyre Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Gyre Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Gyre Therapeutics.
Gyre Therapeutics Fundamental Analysis
We analyze Gyre Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gyre Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gyre Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Gyre Therapeutics is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Gyre Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gyre Therapeutics stock to make a market-neutral strategy. Peer analysis of Gyre Therapeutics could also be used in its relative valuation, which is a method of valuing Gyre Therapeutics by comparing valuation metrics with similar companies.
Peers
Gyre Therapeutics Related Equities
CHKIF | China Southern | 7.32 | ||||
NL | NL Industries | 5.95 | ||||
XFABF | X-FAB Silicon | 5.77 | ||||
RYAAY | Ryanair Holdings | 0.52 | ||||
JUTOY | Jutal Offshore | 0.00 | ||||
SLOFF | Solstad Offshore | 0.00 | ||||
SXT | Sensient Technologies | 0.89 | ||||
AVNT | Avient Corp | 1.96 |
Complementary Tools for Gyre Stock analysis
When running Gyre Therapeutics' price analysis, check to measure Gyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gyre Therapeutics is operating at the current time. Most of Gyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Gyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gyre Therapeutics' price. Additionally, you may evaluate how the addition of Gyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |